Pharmaceutical Executive Training Courses

Executive training courses for the pharmaceutical industry

Diagram 5

Pharma industry’s leading executive training courses

Inpharmation provides the industry’s leading forecasting, pricing and market access pharmaceutical training courses. By attending one of our courses you will gain insight to the following:
  • The timeless principles of forecasting: enduring principles that hold constant even in today’s fast changing environment. Learn from Inpharmation’s decades of experience in providing strategic recommendations to the pharmaceutical industry.
  • Pharma-Specific™ forecasting methodologies and techniques: forecasting agencies frequently use techniques that are inappropriate for the pharmaceutical forecasts. Make sure you know which forecasting approaches to use for your specific business questions.

  • Forecasting approaches specific for your situation: forecasting approaches need to be tailored to your specific situations. Make sure you know which approaches should be used for your brand life-cycle stage, launch countries and therapeutic area.

Click here for more information on CEL executive training courses for forecasting

Click here for more information on CEL executive training courses for pricing and market access

“Europe’s most respected pharma forecasting specialist consultancy.”

Centre for Executive Leadership for Pharma

“The rhythm was perfect…concrete and focused.”

Top 10 Pharma Company

“A great introductory course on the subject for anyone who is new in the field of pricing. Good breadth and overview of the discipline… an expert with vast experience demonstrated in his lecture and anecdotes.”

Top 10 Pharma Company

“Second day was really exciting in terms of learning.”


“Management board and directors usually take decisions out of intuition and not evidence-based research. This is obviously something not logical neither appropriate for such positions of responsibility.”


“…very good and very professional…”

Top 30 Pharma Company

“…an obvious expert who was able to pitch complicated issues at a level people could understand in a second language.”

Top 20 Pharma Company

“Very rich and instructive course that embraces the different variables to include in a forecasting process. I will apply a lot of methods and tools in my daily job.”

Top 10 Pharma Company

“Learnt a lot”.

Top 30 Pharma Company

“Good to follow, very good examples. Just excellent.”

Top 20 Pharma Company

“… I now can challenge the market forecasts in a much more qualified way than before attending this course.”

Global Big Pharma

“…dynamic and constantly illustrating theories with concrete examples.”

Top 20 Pharma Company

“… very valuable experience and I learnt a lot.”


What can evidence-based insights do for you?

Inpharmation champions an evidence-based approach to forecasting for the pharmaceutical industry. By attending this training course you’ll receive a focussed overview of the forecast approaches, models and methodologies that have been proven to work for the pharmaceutical industry. Don’t just take our word for it; Inpharmation are highly rated by 93% of course attendees.

Course participants receive a free course-specific copy of the industry-leading forecasting text by Gary Johnson. A number of the world’s leading pharma companies batch order Gary Johnson’s books to help instil an evidence-based approach to forecasting in their organizations.

To book, please visit

Please send me a free brochure outlining the full syllabus of the course.

We have approaches for each stage of your pharmaceutical product’s lifecycle. Behavior-based pricing and econometric pricing models for early stage assets, Payer summit, Payer conjoint and probabilistic van Westendorp for products coming to market.

We also offer international system models and price-demand elasticity models for products near or past launch.

Running Europe’s leading pharmaceutical pricing for market access executive training courses, we place great importance on transferring knowledge and skills to our clients.


Sales Forecasting for Pharmaceuticals

An evidence-based approach

By Gary Johnson

Value Pricing for Market Access

Evidence-based pricing for pharmaceuticals

By Gary Johnson

Pharma-Specific Conjoint

Evidence-based conjoint analysis for an evidence-based industry

By Gary Johnson

Request one of our book chapters

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top